Growth investors should appreciate Vapotherm, Inc. (VAPO). The company is growing revenues at 18.16% y/y, and its gross profit margin is large. VAPO does not seem undervalued at 5.11x sales, but it seems a name to be followed. Many institutional investors bought stock before the IPO.
With that, investors should review the debt closely. The company does not seem to have money to pay its debt in one to three years. Further sale of equity could lead to share price depreciation.
Source: Prospectus
Source: Prospectus
Business Overview
Founded in 1999 and headquartered in Exeter, New